Kairos Pharma, Ltd. (KAPA) AMEX
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 13.08M |
| Enterprise Value | 8.59M |
| P/E Ratio | -0.24 |
| PEG Ratio | -0.01 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 0.35 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | 0.18 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | 0 |
| Operating Margin | 0 |
AD
Management Effectiveness
| Return On Assets | -1.3 |
| Return On Equity | -0.99 |
Income Statement
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | -5.29M |
| Net Income | -5.45M |
| Diluted EPS | -2.1 |
Balance Sheet
| Total Cash | 2.63M |
| Total Cash/Share | 0.86 |
| Total Debt | 0 |
| Total Debt/Equity | 0 |
| Current Ratio | 11.98 |
| Book Value Per Share | 1.37 |
Price History
| 52-Week Change | -93.3 |
| 52-Week High | 7.7 |
| 52-Week Low | 0.47 |
| Moving Average 50 Days | 1.33 |
| Moving Average 200 Days | 3.05 |
Statistics
| Average Volume | 369,152 |
| Shares Outstanding | 3.39M |
| % Held by Institutions | 4.52 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:7 |
| Last Split Date | September 01, 2026 |
AD
